DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities
Cancers · 10.01.2023 · 15 (2) · 448
DOI: 10.3390/cancers15020448 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 10.01.2023. Verfasst von María Ovejero-Sánchez und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 376 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spanish Ministry of Economy and Competitiveness, FEDER funds, Fundación Mutua Madrileña.
Abstract (Originalsprache)
The DNA damage response (DDR), a set of signaling pathways for DNA damage detection and repair, maintains genomic stability when cells are exposed to endogenous or exogenous DNA-damaging agents. Alterations in these pathways are strongly associated with cancer development, including ovarian cancer (OC), the most lethal gynecologic malignancy. In OC, failures in the DDR have been related not only to the onset but also to progression and chemoresistance. It is known that approximately half of the most frequent subtype, high-grade serous carcinoma (HGSC), exhibit defects in DNA double-strand break (DSB) repair by homologous recombination (HR), and current evidence indicates that probably all HGSCs harbor a defect in at least one DDR pathway. These defects are not restricted to HGSCs; mutations in ARID1A, which are present in 30% of endometrioid OCs and 50% of clear cell (CC) carcinomas, have also been found to confer deficiencies in DNA repair. Moreover, DDR alterations have been described in a variable percentage of the different OC subtypes. Here, we overview the main DNA repair pathways involved in the maintenance of genome stability and their deregulation in OC. We also recapitulate the preclinical and clinical data supporting the potential of targeting the DDR to fight the disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.
- Molecular Medicine Unit, Department of Medicine, University of Salamanca, 37007 Salamanca, Spain.
- Institute of Molecular and Cellular Biology of Cancer (IBMCC), University of Salamanca-Spanish National Research Council, 37007 Salamanca, Spain.
ORCID-Profile: María Ovejero-Sánchez, Rogelio González-Sarmiento, Ana Belén Herrero
Förderung
- Spanish Ministry of Economy and Competitiveness
- FEDER funds
- Fundación Mutua Madrileña
- Institute of Biomedical Research of Salamanca (IBSAL)
Zitieren
APA
Ovejero-Sánchez, M., González-Sarmiento, R., & Herrero, A. B. (2023). DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities. Cancers, 15(2), 448. https://doi.org/10.3390/cancers15020448
Vancouver
Ovejero-Sánchez M, González-Sarmiento R, Herrero AB. DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities. Cancers. 2023;15(2):448. doi:10.3390/cancers15020448
BibTeX
@article{OvejeroSnchez2023,
author = {Ovejero-Sánchez, María and González-Sarmiento, Rogelio and Herrero, Ana Belén},
title = {DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities},
journal = {Cancers},
year = {2023},
volume = {15},
number = {2},
pages = {448},
doi = {10.3390/cancers15020448}
}
EUVIMED